Rheumatoid arthritis has improved with the use of biological disease-modifying anti-rheumatic medications (bDMARDs) (RA). Vasculitis of the skin is a symptom of RA. Furthermore, it has been described as a biotherapy's paradoxical impact. According to the BIOGEAS study group (a Study Group on Autoimmune Diseases of the Spanish Society of Internal Medicine), Vasculitis has been observed in more than 140 instances with anti-TNF (Tumor Necrosis Factor) drugs, but only in two cases with Tocilizumab (TCZ). We present the first case of cutaneous vasculitis that developed while on both anti-TNF and TCZ medication.
Author(S) DetailsSaoussen Miladi
Faculty of Medicine of Tunis, University of Tunis El Manar, Research Unit UR17SP04, 2010 Ksar Said, Tunis, Tunisia and Rheumatology Department. Mongi Slim Hospital, Tunisia.
Kaouther Maatallah
Faculty of Medicine of Tunis, University of Tunis El Manar, Research Unit UR17SP04, 2010 Ksar Said, Tunis, Tunisia and Rheumatology Department, Kassab Institute, Tunisia.
Wafa Hamdi
Faculty of Medicine of Tunis, University of Tunis El Manar, Research Unit UR17SP04, 2010 Ksar Said, Tunis, Tunisia and Rheumatology Department, Kassab Institute, Tunisia.
View Book:- https://stm.bookpi.org/RDMMR-V9/article/view/4605
No comments:
Post a Comment